Buy or sell FDNA stock pre IPO via an EquityZen fund
FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals.
About FDNA Stock
FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals. It offers a genetic search and reference tool called Face2Gene that facilitates detection of facial dysmorphic features and recognizable patterns of human malformations from a facial photo to present a list of matching syndromes with up-to-date references. FDNA's solution enables users to upload photos, search and review genetic resources, and analyze results and offers customized reports and visualization tools. Lior Wolf and Moti Shniberg founded it in 2011, with its headquarters in Boston in Massachusetts.
Chief Scientific Advisor & Co-founder
Chairman & Co-founder